"
Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.
Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.
Notes: Data was converted from local currencies using average exchange rates of the respective year.
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
The Digestive & Intestinal Remedies (Pharmacies) market in Lebanon has been experiencing steady growth in recent years.
Customer preferences: Customers in Lebanon have shown a growing preference for Digestive & Intestinal Remedies purchased from pharmacies. This can be attributed to the trust and convenience associated with purchasing these products from a trusted healthcare professional. Pharmacies provide a wide range of options, including both over-the-counter and prescription medications, allowing customers to find the most suitable remedy for their specific needs. Additionally, the availability of knowledgeable pharmacists who can provide guidance and recommendations further enhances the appeal of purchasing these products from pharmacies.
Trends in the market: One of the key trends in the Digestive & Intestinal Remedies market in Lebanon is the increasing demand for natural and herbal remedies. Customers are becoming more conscious of the ingredients used in the products they consume and are seeking alternatives to traditional pharmaceutical options. This trend is driven by a growing awareness of the potential side effects associated with certain medications, as well as a desire for more holistic and natural approaches to healthcare. As a result, pharmacies in Lebanon are expanding their offerings to include a wider range of natural and herbal Digestive & Intestinal Remedies to cater to this demand.
Local special circumstances: Lebanon has a rich culinary tradition, with a wide variety of flavorful and often spicy dishes. While this is a source of pride for the Lebanese people, it can also lead to digestive issues for some individuals. As a result, there is a high demand for Digestive & Intestinal Remedies in the country. This local special circumstance contributes to the growth of the market, as customers seek effective remedies to alleviate symptoms such as indigestion, heartburn, and bloating.
Underlying macroeconomic factors: Lebanon has a relatively high prevalence of gastrointestinal disorders, which contributes to the demand for Digestive & Intestinal Remedies. Factors such as stress, poor dietary habits, and lifestyle choices can all contribute to the development of these disorders. Additionally, the country's aging population is also a driving force behind the market growth, as older individuals are more likely to experience digestive issues and seek remedies to manage their symptoms. The increasing disposable income and improving healthcare infrastructure in Lebanon also play a role in driving the growth of the Digestive & Intestinal Remedies market, as individuals have greater access to healthcare services and can afford to purchase these products.
Most recent update: Jun 2024
Source: Statista Market Insights
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.